Clinical and molecular features of patients with amyotrophic lateral sclerosis and SOD1 mutations: a monocentric study
Authors:
Open Access
- 17 May 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 14
Abstract
Introduction: SOD1 was the first gene associated with both familial and sporadic forms of amyotrophic lateral sclerosis (ALS) and is the second most mutated gene in Caucasian ALS patients. Given their high clinical and molecular heterogeneity, a detailed characterization of SOD1-ALS patients could improve knowledge about the natural history of this disease. Here, the authors aimed to provide a clinical and molecular description of a monocentric cohort of SOD1-ALS patients.Methods: Amyotrophic lateral sclerosis (ALS) patients referring to the neurology unit of our center between 2008 and 2021 were clinically assessed and underwent molecular testing for SOD1. Segregation studies in available family members and in silico analysis were performed to sustain the pathogenicity of the identified SOD1 variants.Results: Among the 576 patients in our cohort, we identified 19 individuals harboring a mutation in SOD1 (3.3%), including 15 (78.9%) with a familial and four (21.1%) with a sporadic form. The spinal onset of the disease was observed in all patients, and survival was extremely variable, ranging from 8 months to over 30 years. Twelve different SOD1 missense variants were identified in our cohort, including one novel mutation (p.Pro67Leu).Discussion: In the present series, we provided the first description of an Italian monocentric cohort of SOD1-ALS patients, and we expanded the repertoire of SOD1 mutations. Our cohort presents several remarkable features, including variable expressivity in the same family, atypical presentation (ataxia, cognitive impairment, and other extra-motor symptoms), and different modes of inheritance of a given mutation in the same family. Given the recent authorization of SOD1-directed antisense oligonucleotide for use in SOD1-ALS patients, we recommend prompt screening for SOD1 mutations in novel ALS patients with familiar or sporadic presentations.Keywords
This publication has 53 references indexed in Scilit:
- Is SOD1 loss of function involved in amyotrophic lateral sclerosis?Brain, 2013
- Sporadic motor neuron disease in a familial novel SOD1 mutation: Incomplete penetrance or chance association?Amyotrophic Lateral Sclerosis, 2011
- SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlationsJournal of Medical Genetics, 2010
- An unusual case of familial ALS and cerebellar ataxiaAmyotrophic Lateral Sclerosis, 2010
- The p.E22G mutation in the Cu/Zn superoxide-dismutase gene predicts a long survival timeJournal of the Neurological Sciences, 2009
- Electrodiagnostic criteria for diagnosis of ALSClinical Neurophysiology, 2008
- SOD1 gene mutations in Italian patients with Sporadic Amyotrophic Lateral Sclerosis (ALS)Neuromuscular Disorders, 2006
- Identification of three novel mutations in the gene for superoxide dismutase in patients with familial amyotrophic lateral sclerosisNeuromuscular Disorders, 1995
- Amyotrophic Lateral Ssclerosis and Structural Defects in Cu,Zn Superoxide DismutaseScience, 1993
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993